Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Ip Group Plc LSE:IPO London Ordinary Share GB00B128J450 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.00 0.75% 134.40 134.20 134.60 135.00 133.40 133.40 2,125,288 16:29:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 0.0 186.1 17.5 7.7 1,428

Ip Share Discussion Threads

Showing 2051 to 2071 of 2325 messages
Chat Pages: 93  92  91  90  89  88  87  86  85  84  83  82  Older
DateSubjectAuthorDiscuss
07/1/2021
08:55
Wet, posts crossed. Do you have a link?
bamboo2
07/1/2021
08:53
Not sure why the drop this morning, but yesterday's gap up is filled, which is a good thing. Guess Invesco or Lansdowne found a load more down the back of sofa! Added a few more.
bamboo2
07/1/2021
08:46
Looks like Invesco managed to offload the rest of their holding at £1. Would be interesting to find out who picked up these 62m shares.
wetpantz
06/1/2021
17:32
A lucky bag. What will they pull out next?
p1nkfish
06/1/2021
17:04
IP Group plc - Portfolio company Hinge Health completes $300m funding round IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that portfolio company Hinge Health, Inc, a digital clinic for back and joint pain for employers and health plans , has completed a $300m (GBP225m*) Series D investment round valuing the company at approximately $3bn (GBP2.2bn*). Following completion of the investment round, IP Group has an undiluted beneficial holding of approximately 2.4% in Hinge Health that the directors anticipate will be valued at GBP42.1 million, representing a net unrealised fair value gain to the Group of approximately GBP30.7 million. * GBP equivalent using 1.34 USD/GBP
bamboo2
06/1/2021
16:58
At a guess I would say the effect of the overhang/forced sellers is on the wane. Target price at 114 nearly attained. Next resistance point after that approx 120-122
bamboo2
06/1/2021
14:48
By Adam Clark Oxbotica, a U.K. developer of autonomous vehicle software, said Wednesday that it had raised $47 million in a funding round led by the venture investment arm of BP PLC, which also included Chinese internet company Tencent Holdings Ltd. The company, founded in 2014 by professors from the University of Oxford, said the money would accelerate commercial deployment of its software. It is initially focusing on industrial uses before moving on to urban transport. BP Ventures led the Series B funding round as the British oil major looks to invest in technology that could help in its planned diversification as an energy business. In 2018, it acquired the U.K.'s largest electric-vehicle charging company, Chargemaster. China's Tencent also participated in the funding round as it looks to boost its presence in the self-driving sector. Tencent said in 2019 that it was partnering with BMW to launch a computing center in China to develop self-driving technology. Other investors in the round included London-listed IP Group PLC, an early backer of Oxbotica, and FTSE 100 safety-equipment company Halma PLC. The latter said the investment would expand Oxbotica's partnership with Halma's Navtech, a radar technology company. Write to Adam Clark at adam.clark@wsj.com
bamboo2
06/1/2021
07:16
Another positive development ! IP Group plc - Portfolio company Oxbotica completes GBP36m funding round IP Group plc, the developer of intellectual property-based businesses, notes that portfolio company Oxbotica Ltd, a global leader in autonomous vehicle software, has announced that it has raised £36.0m of new capital in a Series B round from both new and existing investors. Following completion of the transaction, IP Group will hold a direct undiluted beneficial stake of 15.0% in Oxbotica. IP Group committed £4.0m to the round which was led by BP Ventures with funding from other investors including BGF, Halma, HostPlus,Tencent, Venture Science and funds advised by Doxa Partners. The funding will be used to accelerate Oxbotica's commercial deployment of its autonomy software platform across multiple industries and key markets. Oxbotica's product is a software platform providing Universal Autonomy. It is fast to deploy, low energy, hassle free, hardware agnostic autonomy and applicable to a vast array of vehicle types both on and off road. The advanced technology supports Oxbotica's unique horizontal B2B model providing operators, integrators and manufacturers the autonomy functionality and flexibility they need be that a full stack or on a component-by-component basis. Jamie Vollbracht, Partner, Cleantech at IP Group plc, said: "Oxbotica provides autonomy where it makes sense today: delivering safety, cost and environmental benefits. Two years after IP Group's first investment, we are delighted to be able to welcome multiple value-adding investors to the share register. This substantial funding round will enable Oxbotica to move to the next stage, delivering those benefits in multiple applications across the globe."
masurenguy
05/1/2021
12:29
Pierre, Sorry, I got the wrong idea from your question! Think you were maybe after separately listed firms. Try here, Zeppo has a HYD bb https://uk.advfn.com/cmn/fbb/thread.php3?id=45595651&from=1104 You could buy more ipo, which would give greater exposure to the 25% of Bramble and RFC they hold!
bamboo2
05/1/2021
08:29
Years ago I studied Biology at school, but the genetics taught then is outdated, and there is new understanding. To this end I enrolled on an online course. It's free, and adopted by the NHS. It's a good place to start, if you want to know your DNA from your RNA! Https://www.futurelearn.com/courses/whole-genome-sequencing
bamboo2
05/1/2021
08:23
ONT v ILLUMINA Viral whole-genome sequencing (WGS) provides critical insight into the transmission and evolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Long-read sequencing devices from Oxford Nanopore Technologies (ONT) promise significant improvements in turnaround time, portability and cost, compared to established short-read sequencing platforms for viral WGS (e.g., Illumina). However, adoption of ONT sequencing for SARS-CoV-2 surveillance has been limited due to common concerns around sequencing accuracy. To address this, here we perform viral WGS with ONT and Illumina platforms on 157 matched SARS-CoV-2-positive patient specimens and synthetic RNA controls, enabling rigorous evaluation of analytical performance. We report that, despite the elevated error rates observed in ONT sequencing reads, highly accurate consensus-level sequence determination was achieved, with single nucleotide variants (SNVs) detected at >99% sensitivity and >99% precision above a minimum ~60-fold coverage depth, thereby ensuring suitability for SARS-CoV-2 genome analysis. ONT sequencing also identified a surprising diversity of structural variation within SARS-CoV-2 specimens that were supported by evidence from short-read sequencing on matched samples. However, ONT sequencing failed to accurately detect short indels and variants at low read-count frequencies. This systematic evaluation of analytical performance for SARS-CoV-2 WGS will facilitate widespread adoption of ONT sequencing within local, national and international COVID-19 public health initiatives. Https://www.nature.com/articles/s41467-020-20075-6#Sec2
bamboo2
04/1/2021
14:21
Pierre, Have a look at Bramble. Bramble is based a stones throw away from CWR HQ. ====================================== Copy of post from 25 October 2020. The sale of CWR means that IPGroup can now focus on Bramble Energy [24.2%] and RFC Power [26.5%]. Both of these constituent companies have team members that originate from the same institution as CWR, Imperial College London. Some were founders of CWR. The companies also share some management. Https://www.brambleenergy.com/ Https://www.rfcpower.com/team
bamboo2
04/1/2021
11:19
Ffs soz about my spell checker, hope the post is understandable.
pierre oreilly
04/1/2021
11:18
Anyone in a helpful mood? I want to get some exposure to the hydrogen fad. For ideas, I firstly look at IPOs holdings to see if they hold any shares in the area I'm interested in. (That's how I got into orph). Seems to me if ipo hold and fund/sponsor them, they must have something going for them and of course, they have access to more cash. Critical for aim stocks. ( A good time to buy is when ipo dispose of their holding!). So, having browsed through their clean tech and tech holdings, none strike me as hydrogen plays. Maybe I'm not looking hard enough. Does anyone know of any hydrogen holdings ipo has? Tia.
pierre oreilly
31/12/2020
13:05
The future for IPO is bright. If they manage to generate a reliable, repeatable, recurring, profit who would be against a progressive dividend policy? Few. However, they are not there and giving away seed corn cash in a business like this is a recipe for decay.
p1nkfish
31/12/2020
11:28
Lol pink.On every point I've raised on here over the last year you have instantly objected.Then 3 months later posted more or less the same as you objected to 3 months earlier.Yes, the 50% hike would disappear once the 50% was paid as a Divi. But, stating the obvious, we'd all be 50% better off than we are now.On the next valuation you'll see explicitly that a quid in the company is worth 50p to shareholders. That's why cash should be paid out, particularly large future cash windfalls. Even more so when you realise that have far more cash sitting around doing nothing far in excess of their foreseeable future investments.You have my permission to copy and paste this post when you agree with it in 3 month's time.
pierre oreilly
31/12/2020
11:11
50% upside would be gone once the cash is disbursed. They will need the money they have looking at some of the investment demands due. Some good new homes for cash coming along imho. UK needs long term Sci investment post Jan 1st onwards, not wheeler dealing. Don't like it, sell and move on. We have allowed our industrial base to erode. Helping reverse that with new industries needs the likes of IPO fully cashed up and ready to deploy.
p1nkfish
31/12/2020
10:54
How about IP learning from one of their past holdings?Open orphan have said that when they float one of their subsids on the nas early next year the indications show, they will return the full proceeds as a Divi to all of holders. The return is likely to be a high percentage of the current orph price - they are pharma companies to be floated and not core to orph.So why don't IP say the same? Get nano floated, and undertake to divide the total proceeds to shareholders? They already have far in excess cash for their foreseeable future.Result? Immediate 50% upsurge on ips share price. Imo.
pierre oreilly
29/12/2020
09:19
Yes bamboo - the end of the day will tell us something. Thanks for input
benchmark
29/12/2020
09:13
Benchmark, Re gaps, it depends what kind of gap it is, a news based breakaway gap can remain unfilled for long periods of time. There is no RNS, but there could be something not visible yet, eg an upgrade? Best wait until eod, and also check last market price based chart.
bamboo2
29/12/2020
09:07
Benchmark, It could be ONT. :-) MXCT, in a similar area of medicine, also on the move. Invesco year end 31/12/2020. I would guess if they are raising more cash for redemptions, it will likely be this week. Similar for Lansdowne afaik.
bamboo2
Chat Pages: 93  92  91  90  89  88  87  86  85  84  83  82  Older
ADVFN Advertorial
Your Recent History
LSE
IPO
Ip
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210418 09:42:52